US › Healthcare

Clearmind Medicine Inc. Common Shares (CMND)

US · Healthcare · Biotechnology

$0.86+6.46%

Last close · 2026-09-17

Latest quarter · ended 2026-07-31

Revenue

Net profit

$-907,291

EPS

$-0.57

Key statistics

Market cap

$1.4M

Forward P/E

0.0

P/B

0.11

Book value

$75.44

EPS (TTM)

$-57.79

52-week high

$524.00

52-week low

$0.92

50-day MA

$1.73

200-day MA

$12.01

Beta

-1.14

Shareholding

Insiders

0.09%

Institutions

3.30%

Largest institutional holders

Fund	Stake
XTX Topco Ltd	0.15%
HRT FINANCIAL LLC	0.11%
AdvisorShares Investments, LLC	0.08%
Royal Bank of Canada	0.00%
UBS Group AG	0.00%
JPMorgan Chase & Co	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Clearmind Medicine Inc. Common Shares — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.